...major depressive disorder (MDD) and post-partum depression (PPD...

...III SKYLARK trial, to treat postpartum depression (PPD).The...
...and the Phase III ROBIN study in PPD...

...C round led by Sapphire Ventures, with participation from existing investors GSR Ventures, PPD Inc. (NASDAQ:PPD...

...indication. Both readouts led to sharp declines in Marinus’ share price (see “Marinus Plummets After PPD...

...a series D1 round led by existing investors Lux Capital, Redmile Group and PPD Inc. (NASDAQ:PPD...

...billion offering by contract researcher PPD Inc., which had a postmoney valuation of $9 billion (NASDAQ:PPD...

...Inc. Lyra Therapeutics Inc. ORIC Pharmaceuticals Inc. Keros Therapeutics Inc. Zentalis Pharmaceuticals Inc. Imara Inc. Passage Bio Inc. Revolution Medicines Inc. Beam Therapeutics Inc. PPD...

...to more than $45 million. GSR Ventures led the round with participation from PPD Inc. (NASDAQ:PPD...

...biopharmas and CROs. Amgen Inc. (NASDAQ:AMGN) and Baxalta were LPs in Fund I, along with PPD LLC...

...largest of the bunch, trailing only the $1.9 billion offering by contract researcher PPD Inc. (NASDAQ:PPD...
...amid worries about U.S. trade with China and the COVID-19 (2019-nCoV) coronavirus. The rest, including PPD...